Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Breast. 2004 Feb;13(1):66-8.

Metastatic breast cancer response after Exemestane withdrawal: a case report.

Author information

  • 1Cancer Centre at the Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK. sabhide@yahoo.com

Abstract

A forty-three year old female patient with right sided breast cancer was treated with adjuvant radiotherapy and Tamoxifen. She had a relapse in the right supraclavicular fossa after a disease free period of 12 years. She progressed, after a short period of disease stabilization on Idoxifene followed by a further stable period on Anastrazole. At further disease relapse, she was commenced on Exemestane. After a period of disease stabilization and subsequent disease progression in the right supraclavicular fossa, Exemestane was discontinued. Six weeks later there was a marked regression of the right supraclavicular mass. Withdrawal response to Tamoxifen is well documented. To our knowledge a similar response after Exemestane withdrawal has not been reported in the literature.

PMID:
14759719
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk